These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33310152)

  • 1. Metformin in acute respiratory distress syndrome: An opinion.
    Uddin MA; Akhter MS; Kubra KT; Siejka A; Barabutis N
    Exp Gerontol; 2021 Mar; 145():111197. PubMed ID: 33310152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen-mediated upregulation of the Mas receptor contributes to sex differences in acute lung injury and lung vascular barrier regulation.
    Erfinanda L; Ravindran K; Kohse F; Gallo K; Preissner R; Walther T; Kuebler WM
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32764118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
    Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
    Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brefeldin A and kifunensine modulate LPS-induced lung endothelial hyperpermeability in human and bovine cells.
    Kubra KT; Barabutis N
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C214-C220. PubMed ID: 34161151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Damage in Acute Respiratory Distress Syndrome.
    Vassiliou AG; Kotanidou A; Dimopoulou I; Orfanos SE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19.
    Borrmann M; Brandes F; Kirchner B; Klein M; Billaud JN; Reithmair M; Rehm M; Schelling G; Pfaffl MW; Meidert AS
    Front Immunol; 2023; 14():1129766. PubMed ID: 36776845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
    Soto M; diZerega G; Rodgers KE
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.
    Dubrovskyi O; Hasten E; Dudek SM; Flavin MT; Chan LL
    SLAS Discov; 2021 Oct; 26(9):1079-1090. PubMed ID: 34269109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.
    Teulier M; Elabbadi A; Gerotziafas G; Lionnet F; Voiriot G; Fartoukh M
    BMC Pulm Med; 2021 Jan; 21(1):46. PubMed ID: 33514354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19.
    Yamaoka-Tojo M
    Biomed J; 2020 Oct; 43(5):399-413. PubMed ID: 33032965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
    Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study.
    Oh TK; Song IA
    Ann Palliat Med; 2020 May; 9(3):903-911. PubMed ID: 32389018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the Host Response as a Therapeutic Strategy in Severe Lung Infections.
    Latreille E; Lee WL
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption.
    Akhter MS; Kubra KT; Barabutis N
    Endocrine; 2023 Mar; 79(3):587-592. PubMed ID: 36261700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.